Get a glimpse into our company and investor data—powered by the PitchBook Platform
CANbridge Life Sciences
Series BLATEST DEAL TYPE
$21MLATEST DEAL AMOUNT
Developer of specialty healthcare products designed to treat critical medical conditions. The company's specialty healthcare products prevent and treat oral mucositis, enabling patients to access improved treatment.